On June 22, 2022 Invectys reported that it will be attending the 9th International Conference on HLA-G (Press release, Invectys, JUN 22, 2022, View Source [SID1234616161]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Focused on the key immunomodulatory molecule HLA-G, this conference aims to cover the research within this field. Advances in oncology, organ transplantation, autoimmune diseases, virology, etc, will be presented.

Invectys will be giving 2 presentations: « Redirection of immune cells specificity against HLA-G: anti HLA-G CAR T Cells« , on July 4th at 12:10, and « Advances in cancer immunotherapy development: new VHH-based immune checkpoint inhibitors targeting the receptor ILT4« , on July 4th at 12:50.